Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-016907-41Phase 4Completed
Phase 4, single-arm trial of propofol and remifentanil, sponsored by Charité – Universitätsmedizin Berlin. Primary endpoints: Dose dependency of BOLD responses after noxious stimulation under propofol and remifentanil and Changes in nociceptive structures measured by fMRI, EEG, and nociceptive reflexes. Started Aug 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-016907-41.